<DOC>
	<DOCNO>NCT00385320</DOCNO>
	<brief_summary>The purpose study test infant respond different strength human rotavirus vaccine .</brief_summary>
	<brief_title>Evaluate Protective Efficacy Diff Strengths Human Rotavirus Vaccine After Admn 2 Doses Infants Aged 2 Months</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male female infant , include , 6 12 week age bear gestation period 36 42 week birth weight &gt; 2000g . Written inform consent obtain parent guardian subject . Planned administration oral polio vaccine period start 2 week dose study vaccine ( ) end 2 week . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection History diphtheria , tetanus , pertussis , Hib disease and/ hepatitis B . Previous vaccination diphtheria , tetanus , pertussis , and/or Haemophilus influenzae type b . History allergic disease Any clinically significant history chronic gastrointestinal disease include uncorrected congenital malformation GI tract serious medical condition determine investigator . Gastroenteritis within 7 day precede study vaccine administration ( warrant deferral vaccination ) Previous confirm occurrence RV GE . Household contact immunosuppressed individual pregnant woman . Administration immunoglobulins and/or blood product since birth plan administration study period</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>